Adherence to guidelines for the management of excessive warfarin anticoagulation

被引:8
作者
Devine, Emily B. [1 ]
Hopefl, Alan W. [2 ]
Wittkowsky, Ann K. [3 ]
机构
[1] Univ Washington, Pharmaceut Outcomes Res & Policy Program, Seattle, WA 98195 USA
[2] Amerinet Inc, St Louis, MO USA
[3] Univ Washington, Sch Pharm, Seattle, WA 98195 USA
关键词
Anticoagulation; Evidence-based guidelines; International normalized ratio (INR); Vitamin K1; Warfarin; ORAL VITAMIN-K; INTERNATIONAL NORMALIZED RATIO; RETROSPECTIVE EVALUATION; PHYTONADIONE; COAGULOPATHY; REVERSAL; THERAPY;
D O I
10.1007/s11239-008-0232-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The American College of Chest Physicians (ACCP) provides guidelines for the management of excessive anticoagulation in patients receiving warfarin. This multi-site prospective cohort study evaluated patient-level practice patterns and adherence to ACCP guidelines. Methods Patients presenting with an INR a parts per thousand yen 4.5 between January 3 and April 29, 2005 were observed and therapeutic management documented. Adherence was assessed retrospectively. Results Four hundred and seventeen patients from 22 centers were observed. The mean, initial INR was 7.7. At enrollment, 85% of the patients had an INR < 9 or were not bleeding; 15% were seriously bleeding. Treatment for 170 patients (41%) did not adhere to guidelines. Among those, 15% were undertreated, 48% overtreated. Lack of adherence was attributed primarily to excessive doses (mean initial dose = 6.9 mg) and inappropriate routes of administration (subcutaneous or intramuscular) of vitamin K1. Conclusion Adherence to the ACCP guidelines is low. Inappropriate use of vitamin K1 is the primary reason.
引用
收藏
页码:379 / 384
页数:6
相关论文
共 25 条
[1]   The pharmacology and management of the vitamin K antagonists [J].
Ansell, J ;
Hirsh, J ;
Poller, L ;
Bussey, H ;
Jacobson, A ;
Hylek, E .
CHEST, 2004, 126 (03) :204S-233S
[2]   Elevated international normalized ratio in the ED: clinical course and physician adherence to the published recommendations [J].
Atreja, A ;
El-Sameed, YA ;
Jneid, H ;
Hoogwerf, BJ ;
Peacock, WF .
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2005, 23 (01) :40-44
[3]   Antithrombotic therapy for venous thromboembolic disease [J].
Büller, HR ;
Agnelli, G ;
Hull, RD ;
Hyers, TA ;
Prins, AH ;
Raskob, GE .
CHEST, 2004, 126 (03) :401S-428S
[4]   Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial [J].
Crowther, MA ;
Julian, J ;
McCarty, D ;
Douketis, J ;
Kovacs, M ;
Biagoni, L ;
Schnurr, T ;
McGinnis, J ;
Gent, M ;
Hirsh, J ;
Ginsberg, J .
LANCET, 2000, 356 (9241) :1551-1553
[5]   Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy - A randomized, controlled trial [J].
Crowther, MA ;
Douketis, JD ;
Schnurr, T ;
Steidl, L ;
Mera, V ;
Ultori, C ;
Venco, A ;
Ageno, W .
ANNALS OF INTERNAL MEDICINE, 2002, 137 (04) :251-254
[6]  
CROWTHER MA, 2007, 21 C INT SOC THROMB
[7]  
DeZee KJ, 2006, ARCH INTERN MED, V166, P391, DOI 10.1001/.391
[8]   A retrospective evaluation of vitamin K1 therapy to reverse the anticoagulant effect of warfarin [J].
Fan, JY ;
Armitstead, JA ;
Adams, AG ;
Davis, GA .
PHARMACOTHERAPY, 2003, 23 (10) :1245-1250
[9]   Prevention of venous thromboembolism [J].
Geerts, WH ;
Pineo, GF ;
Heit, JA ;
Bergqvist, D ;
Lassen, MR ;
Colwell, CW ;
Ray, JG .
CHEST, 2004, 126 (03) :338S-400S
[10]   The use of vitamin K in patients on anticoagulant therapy: A practical guide [J].
Hanslik T. ;
Prinseau J. .
American Journal of Cardiovascular Drugs, 2004, 4 (1) :43-55